
Yuvezzi’s Health Canada submission leads this week’s recap, plus AI front desks, the EMERALD trial, and Alberta’s scope expansion.
Scott Schachter, OD, explains why competition in the optometric marketplace drives innovation, lowers prices, gives more offerings, and provides better ways for ODs to treat patients.
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or MultiMedia Healthcare LLC.





